Washington Post

May 14, 2019

Among the partners named along with Gilead as defendants were Bristol-Myers Squibb and Janssen, a division of Johnson & Johnson. 

https://www.washingtonpost.com/business/economy/gilead-is-accused-of-cutting-anti-competitive-deals-to-extend-profit-on-hiv-drug-cocktails/2019/05/14/94e79c56-75ad-11e9-bd25-c989555e7766_story.html?utm_term=.07c7102b1084